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8 in 10 HIV positive patients’ lost-to-follow up adhere to ART. Interventions such 
as comprehensive HIV training targeting health worker attitudes and perceptions 
of HIV positive patients such as pre- and post HIV test counseling may further 
improve ART adherence.
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Objectives: The scale up of HIV services and access to anti-retroviral therapy in 
Africa has been made possible in the last 10 years. However, it is important that 
more sustainable “in country” options are explored for sustainability of services. 
The adult HIV clinic at the Infectious Diseases Institute (IDI) in Kampala, Uganda 
has approximately 8000 registered patients who receive care free of charge. We are 
exploring the possibility that some patients are willing /able to contribute to the 
cost of their care. Our objective was to explore attitudes and perceptions of patients 
and staff towards using a fee-based “after hours” clinic (AHC) at IDI. MethOds: We 
employed a cross-sectional, qualitative design. A purposeful sample of 188 adults 
which included current HIV clients and IDI staff was stratified by gender and age. We 
conducted 14 focus group discussions and 55in-depth interviews. Thematic content 
analysis was conducted and Nvivo Software used to manage data. Results: There 
were six key themes that emerged regarding participant perceptions of the AHC. 
Access to care (positive and negative), benefits and disadvantages of an AHC, key 
categories of health care services, recommending the service to friends, sliding scale 
fee-for-service, and suggestions to improve service delivery. Results suggested that 
some respondents were willing to pay for consultation, brand-name drugs, lab tests 
and other services. All were willing to recommend friends/ relatives. Respondents 
agreed that, as a sign of social responsibility, some money could be used to help 
underprivileged patients cOnclusiOns: Our AHC clinic is perceived as beneficial 
to patients because it provides access to HIV services at convenient times. Many 
patients are willing to pay for this enhanced service. Promotion of quality private-
public partnerships aiming to sustain quality HIV services in Uganda should be 
encouraged.
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Objectives: People with human immunodeficiency virus (HIV) have increased risk 
of cardiovascular disease (CVD), kidney disease, and low bone mineral density. Some 
antiretroviral therapies (ART) further increase the risk of these events. The purpose of 
this study was to estimate health state utilities associated with these risks so that the 
values may be used in cost-utility models. MethOds: Qualitative thematic analysis 
was conducted to examine 4,122 messages posted to the POZ/AIDSmeds Internet 
Community Forums from 2008 to 2014. This analysis assessed member awareness of, 
concerns about, and treatment changes due to bone, kidney, and heart-related side 
effects and risks of HIV/AIDS medications. Then, health state vignettes were drafted 
based on this qualitative analysis, literature review, and clinician interviews. The 
health states (representing HIV, plus treatment-related risks) were valued in time 
trade-off (TTO) interviews with general population participants in the UK (London, 
Edinburgh). Results: Quantitative analysis of the Internet forums documented 
patient concerns about ART risks, as well as treatment decisions made because of 
these risks. A total of 208 participants completed utility interviews (51.4% female; 
mean age 44.6y). The mean (SD) utility of the basic HIV health state (describing a viro-
logically suppressed patient treated with ART) was 0.86 (0.14). Adding a description 
of risk to this basic health state was associated with statistically significant disutility 
(i.e., utility decreases): risk of renal problems (disutility = -0.02), risk of bone problems 
(-0.03), and risk of myocardial infarction (-0.05). Health states including the medical 
conditions themselves, rather than risk, had larger disutilities (e.g., stage 4 chronic 
kidney disease; disutility = -0.19). cOnclusiOns: The vignette-based TTO method 
was feasible for quantifying the utility impact of ART-related risks, demonstrating 
small but consistent disutilities. These disutilities may be used in cost-utility models 
comparing the value of treatments for patients with HIV.
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Objectives: The introduction of effective ART in HIV has led to substantial reduc-
tions in morbidity and mortality. However adverse events (AEs) associated with ARTs 
can lead to discontinuation, and worsening of health-related quality of life (HRQL). 
This study aimed to elicit societal disutility values for CNS side effects associated 
with ARTs in France. MethOds: Health states (HS) were developed from interviews 
with HIV patients (N= 9) and one specialist clinician in France. HS were developed to 
describe a stable HIV health state (on treatment), and nine CNS side effects associated 
with ARTs (abnormal dreams, insomnia, anxiety and depression, suicidal thoughts, 
balance and coordination problems, attention difficulties, dizziness, headaches and 
somnolence). Draft HS were reviewed and refined in interviews with patients and 
clinicians (N= 4 in total). The revised HS were piloted with general public to check 
understanding and then evaluated by 100 members of the public in France using 
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Objectives: Annual trivalent influenza vaccines (TIV) containing three influenza 
strains (A/H1N1, A/H3N2, and one B) have been recommended in Panama since 2006. 
However, worldwide co-circulation of two distinct B lineages (Victoria and Yamagata) 
and difficulties in predicting which lineage will predominate in the next season have 
led to the development of quadrivalent influenza vaccines (QIV) including both B 
lineages. Our analysis evaluates the public health and economic benefits of using 
QIV versus TIV in Panama from 2006 to 2013. MethOds: A static model published 
by Reed et al. in 2012 was adapted to Panama and stratified by age group. In addition, 
B-lineage cross-protection was included based on published sources. We calculated 
the hypothetical impact of QIV compared with TIV over seven influenza seasons 
(2009 pandemic year excluded) using virologic circulation, vaccine coverage, vaccine 
effectiveness and attack rate. In absence of B-lineage distribution in Panama, Brazilian 
data were considered. For influenza-related outcomes (outpatient visits, hospitalisa-
tions, deaths), two sets of inputs were used. Influenza-related costs were estimated 
from societal perspective in Panamanian balboas (1 per US dollar). Results: Over 
the 2006-2013 period, QIV would have prevented 7,519 influenza B cases compared 
with TIV, averting between 2,756 and 5,564 outpatients visits, between 28 and 2,202 
hospitalisations and between 6 and 930 deaths. This translates into influenza-related 
avoided costs of between 137 and 3,599 thousand balboas. In 2012, year with high 
B circulation and mismatch, QIV would have avoided 5,256 cases, 3,889 outpatient 
visits, 1,539 hospitalisations, 650 deaths and 2.5 million balboas of influenza-related 
costs in the upper bound. cOnclusiOns: The wider protection offered by QIV would 
reduce the number of influenza infections and its related complications, leading to 
influenza-related costs avoided. Herd effect was not taken into account, underesti-
mating the benefits of QIV vaccination. More robust local data are needed to better 
assess benefits of QIV.
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Objectives: Annual trivalent influenza vaccines (TIV) containing three influenza 
strains (A/H1N1, A/H3N2, and one B) have been recommended in Colombia since 
2007. However, worldwide co-circulation of two distinct B lineages (Victoria and 
Yamagata) and difficulties in predicting which lineage will predominate in the 
next season have led to the development of quadrivalent influenza vaccines (QIV) 
including both B lineages. Our analysis evaluates the public health and economic 
benefits of using QIV versus TIV in Colombia from 2007 to 2014. MethOds: A 
static model published by Reed et al. in 2012 was adapted to Colombia and strati-
fied by age group. In addition, B-lineage cross-protection was included based on 
published sources. We calculated the hypothetical impact of QIV compared with 
TIV over seven influenza seasons (2009 pandemic year excluded) using virologic 
circulation, vaccine coverage, vaccine effectiveness and attack rate. In absence of 
B-lineage distribution in Colombia for 2007-2013, Brazilian data were considered. 
For influenza-related outcomes (outpatient visits, hospitalisations, deaths), two 
input sets were used. Influenza-related costs were estimated from societal per-
spective in Colombian pesos (0.00052 per US dollar in 2013). Results: Over the 
2007-2014 period, QIV would have prevented 27,957 influenza B cases compared 
with TIV, averting between 10,450 and 19,188 outpatient visits, between 492-7,549 
hospitalisations and between 31-2,028 deaths. This translates into influenza-related 
avoided costs of between 1.7 and 12.5 billion pesos. In 2014, year with high B circula-
tion and mismatch, QIV would have avoided 14,771 cases, 10,138 outpatient visits, 
3,989 hospitalisations, 1,071 deaths and 6.6 billion pesos of influenza-related costs 
in the upper bound. cOnclusiOns: The wider protection offered by QIV would 
reduce the number of influenza infections and its related complications, leading 
to influenza-related costs avoided. Herd effect was not taken into account, under-
estimating the benefits of QIV vaccination. More robust local data are needed to 
better assess benefits of QIV.
INfEctIoN – Patient-reported outcomes & Patient Preference studies
PIN82
AdHErENcE to ANtIrEtrovIrAl tHErAPy AmoNg PAtIENts lost-to-
follow uP: A cAsE of AN HIv clINIc IN A PrIvAtE-for-ProfIt HEAltH 
fAcIlIty IN kAmPAlA, ugANdA
Anguzu R, Turyagyenda F
Makerere University School of Public Health, Kampala, Uganda
Objectives: To determine the level of adherence to ART among HIV positive 
patients lost-to-follow in an HIV clinic in a private-for-profit health facility in 
Kampala district, Uganda. MethOds: A cross-sectional study design was con-
ducted in an HIV clinic in Kampala district. Medical records of 550 HIV positive 
attending the HIV clinic from April 2005 to April 2012 in a private-for-profit health 
facility were analyzed. Per ART dataset, 147 HIV positive patients were identified as 
being lost-to-follow up to HIV care among which 94 were accessible for interviews. 
Loss-to-follow up was regarded as HIV positive patients who had not attended 
ART clinic for a period or 4 or more months. A telephone interview was conducted 
using a pretested structured questionnaire in order to assess adherence to ART and 
factors associated with loss to follow up from the ART clinic. Results: The level of 
adherence to ART was 77.7% while level of loss to follow up was 26.7%. Predictors of 
adherence to ART were; distance from health facility (AOR = 0.01, 95% CI = 0.00-0.35), 
health worker attitude (AOR = 9.43, 95% CI = 1.55 – 57.43) and patients perception of 
lifetime ART medication (AOR = 26.54, 95% CI = 3.33 – 211.2) cOnclusiOns: About 
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(MPR) and Single Tablet Regimens (STR). Validated and self-reported questionnaires 
(ISS-QoL, EQ-5D-3L and CES-D) were administered to collect social and clinical data, 
QoL measure and adherence information, both at baseline and follow-up (6 months). 
The correlations between i) perceived QoL and the above mentioned variables, ii) 
determinants and/or predictors of the QoL, were investigated. Results: 300 ques-
tionnaires were delivered and 174 were completed. MPR and STR populations were 
comparable for all personal details, with similar immunological and virological 
effectiveness. Patients receiving STR declared a higher QoL than individuals using 
MPR (P= 0.004). Non-adherence, depression, lack of wellbeing and higher number 
of comorbidities lead to worse QoL (P< 0.05). The predictors of QoL in HIV-infected 
individuals were duration of HIV infection (P= 0.00), wellbeing measures (P= 0.01), 
years of treatment (P= 0.007) and viral load (P= 0.003). cOnclusiOns: Although 
literature showed that QoL depends on CD4 count, the results of our study suggested 
that in the Italian setting, immunological effectiveness is not a determinant and a 
predictor of QoL variation. Regimen treatment impacts on adherence and compli-
ance: simplification strategies could improve QoL patients perception.
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Objectives: To study the influence of symptom experience and clinical mark-
ers on a multidimensional Health-related quality of life (HRQL) questionnaire 
specific to HIV using sparse PLS regression and Canonical Correlation Analysis 
(RGCCA). MethOds: Self-reports were collected during the Vespa2 national 
survey, including: the 8-dimension PROQOL-HIV questionnaire, a 22-symptom 
checklist, and 22 binary clinical indicators. Complete cases for all three blocks 
of data were considered in this analysis: N= 1524 patients undergoing ART, age = 
47, 77% men, 51% MSM, 80% undetectable viral load. Data were analysed using 
bootstrapped sparse PLS (HRQL and symptoms only) and RGCCA (three blocks), 
with hyper-parameters (number of components, κ , and L1 penalty, λ ) optimised 
through 10-fold cross-validation. The HRQL block was never penalised. Results: 
Sparse PLS (κ = 4, λ = 0.65) selected 15 symptoms where sexual dysfunction, lipod-
ystrophy, depression had the highest negative loadings on relevant dimensions 
of the PROQOL-HIV dimensions (sexual relationships, body changes, emotional 
distress). Fatigue, anxiety, and sleep disorder cross-loaded on all but the body 
changes dimension. Using three-block RGCCA (λ = 0.7), the top symptoms (loadings) 
on the first component (44% of average variance explained) were anxiety (0.52), 
depression (0.51), and fatigue (0.48), while gender (-0.68), chronic HCV (0.61) and 
living mode (0.30) were the most important clinical predictors. Model-based cluster 
analysis of first component scores highlighted four equal-size clusters of patients 
accounting for important individual factors: chronic HCV, MSM vs. women, living 
alone, disease duration. cOnclusiOns: Using sparse multi-block modelling of 
HRQL, symptom experience, and clinical markers allows to study both variables 
relationships and individual profiles of respondents. Accounting for the differen-
tial impact of symptoms and clinical factors on several dimensions of a specific 
HRQL questionnaire provides interesting perspectives in health management and 
treatment monitoring for HIV patients.
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Objectives: To validate a new international questionnaire to assess Health-
Related Quality of Life (HRQL) in patients living with HCV. Existing tools used in 
HCV were mostly generic and missing important concepts such as impact of the 
treatment. MethOds: 660 HCV mono-infected or HIV co-infected patients included 
in a cross-sectional survey in 3 countries (France [59%], Brazil [30%], and Australia 
[11%]) completed paper- or internet-based version of 3 HRQL questionnaires and 
symptom, sociodemographic and biomedical checklist. Psychometric item analysis 
and factor analysis were used to reduce the original 72-item PROQOL-HVC question-
naire. Reliability (Cronbach’s alpha), convergent validity (EQ-5D, SF-12, symptoms), 
and clinical validity (biological markers) were assessed on the final version using 
correlation and two-group comparison at a fixed 5% level. Results: Sample char-
acteristics: 57% men, 52 years, 80% vocational level and higher, 35% living alone. 
Regarding comorbidities and treatment status: 35% co-infected with VIH (95% under 
ART), 15% not treated, 25% undergoing interferon, 35% ribavirine, 43% Direct-Acting 
Antivirals (35% without associated interferon); 27% depressive (71% treated). The 
PROQOL-HCV questionnaire was reduced to 38 items spanning 7 dimensions scored 
on a 100-point scale: Physical Health (PH, 6 items, α = 0.90), Emotional Health (EH, 
9 items, α = 0.93), Future Uncertainty (FU, 6 items, α = 0.79), Intimate Relationships 
(IR, 3 items, α = 0.86), Social Health (SH, 3 items, α = 0.47), Cognitive Functioning (CF, 
3 items, α = 0.80), and Treatment Impact (TI, 8 items, α = 0.61). Pearson correlations 
of PROQOL-HCV dimension with the EQ5-D (general health) and SF-12 mental and 
physical composites were in the acceptable range. The PH dimension was negatively 
correlated to the number of bothersome symptoms (p< 0.001). Lower HRQL (PH, EH, 
CF) was reported in women (p< 0.01), depressive patients (p< 0.001), patients under 
interferon (p< 0.01, except CF), patients without treatment (p< 0.01). cOnclusiOns: 
PROQOL-HCV questionnaire is valid and contains new dimensions such as Intimate 
Relationship, Social Health and Treatment impact.
the time trade-off method. Results: The sample (N= 100) demographics were rep-
resentative of the general population of France by age, gender and education level. 
The stable HS had a utility value of 0.95. The disutility of the CNS side effects ranged 
from -0.09 (abnormal dreams) to -0.62 (suicidal thoughts) from the stable state. The 
disutility values for the other side effects were: -0.11 (headaches), -0.12 (attention 
difficulties, insomnia), -0.18 (somnolence), -0.19 (dizziness), -0.25 (balance and coor-
dination problems) and -0.37 (anxiety and depression). cOnclusiOns: The results 
suggest CNS side effects cause significant burden and impact on HRQL. Society places 
particular value in avoiding AEs such as suicidal thoughts, anxiety and depression 
and balance and coordination problems. These utility values highlight the negative 
impact of AEs and can be used in economic evaluations.
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Objectives: To assess knowledge, attitude and perception of Polio (Poliomyelitis) 
among general public in Pakistan and to recommend suitable measures in order to 
improve the awareness of this perilous disease. MethOds: A cross-sectional study 
was conducted on a newly developed, validated and structured self-administered 
research tool and data was collected by interviews. Face and content validity of 
the research tool was done by various healthcare individuals including academics, 
physicians, pharmacists and senior nurses. The research tool was also piloted on 
15 healthcare providers in a different hospital before start of the study. A p-value 
< 0.05 was considered statistically significant. Results: The findings of the study 
revealed that out of 1250 participants, 87.5% were males while 12.5% were females. 
11.2% of the participants believed that vaccination was prohibited in religion, 85.4% 
participants were aware of Polio disease, and 84.5% believed that disease could 
be prevented by giving vaccines to children. 82.3% participants gave vaccine to 
their children whereas 55.2% knew the schedule of the vaccine for their children. 
This study also found that 88.8% of the participants wanted to eradicate disease 
from Pakistan. cOnclusiOns: The results of the study revealed that people have 
adequate knowledge about Poliomyelitis and wanted to eradicate it from Pakistan 
by participating in vaccination activities but still there are few who believe that Polio 
vaccine cannot prevent the disease.
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Objectives: In India, Human immunodeficiency virus (HIV) infected patients lacks 
knowledge on highly active antiretroviral therapy (HAART) leading to non-adherence.
The study was conducted to assess the effect of pharmacist counseling on HAART 
and Patient reported outcomes related to Knowledge, Attitude, Belief and Practice 
(KABP) behavior. MethOds: A prospective study was conducted with Institutional 
Ethics Committee Approval, at tertiary care teaching hospital, from October 2011 to 
June 2012. People living with HIV (PLH) were counseled by a pharmacist with vali-
dated (KABP) questionnaires and data scores of (KABP) responses were assessed at 
the base-line, pre and post counseling.Counseling was on safe use of HAART, signifi-
cance of HAART adherence. Pearson chi-square test was used to compare baseline 
Pre- KABP and Post- KABP responses with follow-ups. Results: A total 120 PLH (89 
males, 31 females) were counseled. The PLH were counseled on tenofovir + emtricit-
abine + efavirenz followed by zidovudine + lamivudine + nevirapine therapy. At the 
baseline 94(78.3%) knew the mode of HIV transmission and 60(50%) were not aware 
about the content of HAART. Aftet pharmacist counseling, 58.3% (p< 0.001) of patients 
knew about the content of HAART. Knowledge score was (p< 0.001) higher in the 
literate group (51.7%) compared to Illiterate group (48.3%). Patients attitude, beliefs 
related to HAART, were found to be (p< 0.05) and 78% (p< 0.001) patients were aware 
that lifelong HAART therapy is needed. In comparison, from base line counseling 
responses of (33%) to post counseling responses of (67.5%) of PLH realized that HAART 
improves immunity cOnclusiOns: Pharmacist counseling removed social stigma, 
and increased self-efficacy beliefs to maintain adherence to HAART.
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Objectives: Psychological, social, wellbeing factors and adherence emerged as key 
issues for measuring the HIV-infected patients quality of life (QoL). In the literature, 
but in Italian evidences in particular, there is a lack of indication concerning i) a 
specific “country-oriented” QoL measure, ii) its relationship among immunological 
(CD4) and virological (VL) status and iii) determinants and predictors of HIV-patients 
QoL. The aim of the study was to examine the QoL, adherence, wellbeing, depression, 
CD4 and VL, in an Italian unselected cohort of patients receiving stable antiretroviral 
treatment. MethOds: A multicenter, prospective study was conducted, involving 3 
Infectious Diseases centers in Lombardy Region. Two groups of patients were consid-
ered, depending on the therapeutic strategy characteristics: Multiple Pill Regimens 
